Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy

K. M. Dolman, A. E.G.Kr von dem Borne, R. Goldschmeding, R. D.B. Gans, Aj M. Donker, Th J. Vervaat, G. Zevenbergen, D. Maingay, R. E. Nikkels, A. E.G.Kr von dem Borne, R. Goldschmeding

Research output: Contribution to journalArticleAcademicpeer-review

291 Citations (Scopus)

Abstract

Vasculitis is a rare complication of propylthiouracil therapy. Antineutrophil cytoplasmic antibodies (ANCA) have been described in association with several vasculitic disorders. We report detection of ANCA against human neutrophil elastase, proteinase 3, and myeloperoxidase in serum from six patients who developed evidence of vasculitis during propylthiouracil treatment of hyperthyroidism. On withdrawal of the drug ANCA concentrations fell and clinical symptoms resolved completely.

Original languageEnglish
Pages (from-to)651-652
Number of pages2
JournalThe Lancet
Volume342
Issue number8872
DOIs
Publication statusPublished - 11 Sept 1993

Fingerprint

Dive into the research topics of 'Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy'. Together they form a unique fingerprint.

Cite this